- MONA for ACS
- Morphine, Oxygen (if hypoxic), Nitrates, Aspirin — early measures in acute coronary syndrome; add a P2Y12 inhibitor and anticoagulation.
- CHA₂DS₂-VASc
- Stroke-risk score in atrial fibrillation; ≥2 (men) or ≥3 (women) generally warrants anticoagulation.
- CURB-65
- Pneumonia severity score: Confusion, Urea >7, Respiratory rate ≥30, BP low, age ≥65 — guides admission.
- STEMI definition
- ST-elevation MI: new ST elevation at the J point in ≥2 contiguous leads (or new LBBB) with ischemic symptoms — needs emergent reperfusion (PCI preferred).
- NSTEMI vs unstable angina
- Both lack ST elevation; NSTEMI has elevated troponin (myonecrosis), unstable angina does not.
- First-line for STEMI reperfusion
- Primary percutaneous coronary intervention (PCI) within 90 minutes; fibrinolysis if PCI not available in time.
- HFrEF guideline therapy
- The 4 pillars: ARNI/ACEi/ARB, beta-blocker, mineralocorticoid antagonist (MRA), and SGLT2 inhibitor.
- HFpEF
- Heart failure with preserved EF (≥50%); treat volume with diuretics, control BP/comorbidities; SGLT2 inhibitors now recommended.
- BNP / NT-proBNP
- Natriuretic peptides released by ventricular stretch; elevated in heart failure, helpful to rule out HF in dyspnea.
- Atrial fibrillation management
- Rate control (beta-blocker or non-DHP CCB) or rhythm control + anticoagulation by CHA₂DS₂-VASc.
- Aortic stenosis triad
- Angina, syncope, and heart failure; harsh crescendo–decrescendo systolic murmur radiating to carotids — replace the valve once symptomatic.
- Mitral regurgitation murmur
- Holosystolic murmur at the apex radiating to the axilla.
- Aortic regurgitation
- Early diastolic decrescendo murmur, wide pulse pressure, water-hammer pulse.
- Hypertensive emergency
- Severe BP elevation with acute target-organ damage; lower MAP ~10–20% in the first hour with IV agents.
- Statin indications (ASCVD)
- Clinical ASCVD, LDL ≥190, diabetes age 40–75, or elevated 10-year risk — high-intensity statin for most ASCVD.
- Wells criteria
- Pretest probability tool for DVT/PE that guides D-dimer vs imaging.
- Long-QT danger
- Predisposes to torsades de pointes; avoid QT-prolonging drugs and correct low K⁺/Mg²⁺/Ca²⁺.
- Pericarditis ECG
- Diffuse ST elevation with PR depression; pleuritic chest pain relieved by sitting forward, with a friction rub.
- Cardiac tamponade (Beck triad)
- Hypotension, muffled heart sounds, and jugular venous distension; pulsus paradoxus is a key clue.
- Stable angina first-line
- Beta-blocker and/or nitrates for symptoms, plus aspirin and a statin; PCI/CABG for refractory or high-risk disease.
- Digoxin toxicity
- Nausea, visual halos/yellow vision, arrhythmias; worsened by hypokalemia — treat with digoxin-specific Fab if severe.
- Wolff-Parkinson-White
- Accessory pathway (delta wave, short PR); avoid AV-nodal blockers in WPW with atrial fibrillation.
- Acute decompensated HF treatment
- IV loop diuretics for congestion; vasodilators if hypertensive; treat the precipitant.
- Peripheral artery disease (ABI)
- Ankle-brachial index ≤0.90 is diagnostic; treat with exercise, statin, antiplatelet, and risk-factor control.
- COPD vs asthma reversibility
- Asthma airflow obstruction is largely reversible with a bronchodilator; COPD is incompletely reversible (post-bronchodilator FEV1/FVC <0.70).
- Asthma stepwise therapy
- Inhaled corticosteroid is the controller cornerstone; add LABA, then escalate. SABA for rescue (or ICS-formoterol as both).
- COPD exacerbation management
- Bronchodilators, systemic corticosteroids, and antibiotics if increased sputum purulence; consider NIPPV for respiratory failure.
- PE diagnosis
- CT pulmonary angiography is the test of choice; D-dimer rules out if pretest probability is low/moderate.
- Massive PE treatment
- Hemodynamic instability → systemic thrombolysis (or embolectomy) plus anticoagulation.
- Light's criteria
- Distinguishes exudative from transudative pleural effusion (pleural/serum protein or LDH ratios, or pleural LDH).
- ARDS
- Acute hypoxemic respiratory failure with bilateral infiltrates not from cardiac edema; treat with low-tidal-volume (lung-protective) ventilation.
- Sepsis bundle
- Early lactate, blood cultures before antibiotics, broad-spectrum antibiotics within 1 hour, and 30 mL/kg crystalloid for hypotension/lactate ≥4.
- Septic shock vasopressor
- Norepinephrine is first-line after fluid resuscitation.
- Idiopathic pulmonary fibrosis
- Progressive restrictive ILD; honeycombing/UIP pattern on HRCT; antifibrotics (pirfenidone, nintedanib) slow decline.
- Solitary pulmonary nodule
- Risk-stratify by size, growth, and patient risk; compare with old films; biopsy/PET for intermediate-to-high risk.
- Obstructive sleep apnea
- Repetitive upper-airway collapse causing daytime sleepiness; diagnosed by polysomnography; treat with CPAP.
- Pulmonary hypertension
- Mean PA pressure ≥20 mmHg; right heart catheterization confirms; classify into 5 WHO groups.
- Spontaneous pneumothorax
- Sudden pleuritic dyspnea; tension pneumothorax (hypotension, tracheal deviation) needs immediate needle/finger decompression.
- Restrictive vs obstructive PFTs
- Obstructive: low FEV1/FVC. Restrictive: normal/high ratio with low total lung capacity.
- Hospital-acquired pneumonia
- Pneumonia ≥48 h after admission; cover Pseudomonas and MRSA per local risk/antibiogram.
- GERD alarm features
- Dysphagia, odynophagia, weight loss, bleeding, anemia, or age >60 with new symptoms → endoscopy.
- Peptic ulcer cause
- H. pylori and NSAIDs are the leading causes; test-and-treat H. pylori.
- H. pylori triple therapy
- A PPI plus clarithromycin and amoxicillin (or quadruple therapy with bismuth in high-resistance areas).
- Upper vs lower GI bleed
- Upper (proximal to ligament of Treitz): melena, high BUN/Cr ratio. Lower: hematochezia.
- Ulcerative colitis vs Crohn
- UC: continuous, mucosa-only, rectum-up, colon only. Crohn: skip lesions, transmural, mouth-to-anus, with fistulae/granulomas.
- C. difficile treatment
- Oral vancomycin or fidaxomicin first-line; stop the offending antibiotic; fecal transplant for recurrence.
- Acute pancreatitis diagnosis
- 2 of 3: characteristic epigastric pain, lipase/amylase ≥3× upper limit, or imaging findings; gallstones and alcohol are top causes.
- Cirrhosis complications
- Varices, ascites, spontaneous bacterial peritonitis, hepatic encephalopathy, and hepatorenal syndrome.
- SBP diagnosis
- Ascitic fluid neutrophils (PMNs) ≥250/µL; treat empirically with a third-generation cephalosporin.
- Hepatic encephalopathy treatment
- Lactulose (titrate to 2–3 stools/day) ± rifaximin; identify the precipitant.
- Acute liver failure (acetaminophen)
- N-acetylcysteine is the antidote; use the Rumack-Matthew nomogram to guide treatment.
- Hemochromatosis
- HFE iron overload; elevated transferrin saturation and ferritin; treat with phlebotomy.
- Celiac disease
- Gluten-sensitive enteropathy; anti-tissue-transglutaminase IgA screen, confirm with duodenal biopsy (villous atrophy).
- Colorectal cancer screening
- Begin at age 45 for average risk (colonoscopy or stool-based tests).
- Diverticulitis
- Left-lower-quadrant pain, fever; CT confirms; uncomplicated cases may be managed with or without antibiotics.
- IBS diagnosis
- Recurrent abdominal pain related to defecation with altered stool form/frequency; a clinical (Rome) diagnosis after excluding alarm features.
- Community-acquired pneumonia outpatient
- Amoxicillin or doxycycline (or a respiratory fluoroquinolone) for healthy outpatients without comorbidities.
- Infective endocarditis (Duke criteria)
- Combines positive blood cultures and echo vegetations with minor criteria to diagnose; get 3 blood-culture sets before antibiotics.
- MRSA coverage
- Vancomycin, linezolid, or daptomycin (not daptomycin for pneumonia — inactivated by surfactant).
- Neutropenic fever
- ANC <500 with fever; start empiric anti-pseudomonal beta-lactam (e.g., cefepime) immediately.
- HIV when to start ART
- Start antiretroviral therapy in everyone with HIV regardless of CD4 count.
- PCP prophylaxis
- TMP-SMX when CD4 <200 (or thrush/AIDS-defining illness).
- Latent TB treatment
- Positive IGRA/PPD with no active disease → isoniazid, rifampin, or combination short-course therapy.
- Active TB regimen (RIPE)
- Rifampin, Isoniazid, Pyrazinamide, Ethambutol for the initial 2-month phase.
- Meningitis empiric therapy
- Vancomycin + ceftriaxone; add ampicillin for Listeria if >50 or immunocompromised; dexamethasone for pneumococcal.
- Pyelonephritis
- Flank pain, fever, pyuria; treat with a fluoroquinolone or third-gen cephalosporin per local resistance.
- Cellulitis vs necrotizing fasciitis
- Necrotizing infection: pain out of proportion, rapid spread, crepitus, systemic toxicity — a surgical emergency.
- Sepsis source control
- Drain abscesses, remove infected lines/devices, debride necrotic tissue alongside antibiotics.
- Hepatitis B serologies
- HBsAg = infection; anti-HBs = immunity; anti-HBc IgM = acute; HBeAg = high infectivity.
- Hepatitis C
- Screen all adults once; direct-acting antivirals cure most patients.
- Antibiotic stewardship
- Narrow therapy once cultures return, use the shortest effective duration, and de-escalate to limit resistance.
- Septic arthritis
- Acute mono-arthritis; arthrocentesis (WBC often >50,000) before antibiotics; drain the joint.
- Rheumatoid arthritis
- Symmetric small-joint (MCP/PIP) inflammatory arthritis with morning stiffness >1 h; anti-CCP and RF positive.
- RA first-line DMARD
- Methotrexate is the anchor disease-modifying drug.
- SLE diagnosis
- Multisystem autoimmune disease; ANA is sensitive (screen), anti-dsDNA and anti-Smith are specific.
- Lupus nephritis monitoring
- Follow anti-dsDNA, complement (C3/C4 fall with flares), urinalysis; biopsy guides therapy.
- Gout
- Monosodium urate crystals — negatively birefringent, needle-shaped; acute treat with NSAIDs, colchicine, or steroids.
- Gout urate-lowering
- Allopurinol (xanthine oxidase inhibitor) for recurrent attacks/tophi; target urate <6 mg/dL.
- Pseudogout (CPPD)
- Calcium pyrophosphate crystals — positively birefringent, rhomboid; chondrocalcinosis on X-ray.
- Giant cell arteritis
- Headache, jaw claudication, vision loss, high ESR in age >50; start high-dose steroids immediately, then biopsy.
- Polymyalgia rheumatica
- Proximal shoulder/hip girdle pain and stiffness with high ESR; dramatic response to low-dose steroids; associated with GCA.
- Seronegative spondyloarthritis
- Ankylosing spondylitis, psoriatic, reactive, IBD-associated; HLA-B27, inflammatory back pain, enthesitis.
- Ankylosing spondylitis
- Young adult inflammatory low back pain improving with exercise; sacroiliitis; 'bamboo spine'.
- Systemic sclerosis
- Skin thickening, Raynaud, anti-Scl-70 (diffuse) or anti-centromere (limited/CREST); watch renal crisis and PAH.
- Sjögren syndrome
- Dry eyes and mouth; anti-Ro (SSA)/anti-La (SSB); increased lymphoma risk.
- Osteoarthritis vs inflammatory
- OA: worse with use, brief (<30 min) stiffness, no systemic signs; treat with exercise, weight loss, and analgesics.
- ANCA-associated vasculitis
- GPA (c-ANCA/PR3) and MPA (p-ANCA/MPO); pulmonary–renal syndrome; induce remission with steroids + rituximab/cyclophosphamide.
- Fibromyalgia
- Chronic widespread pain, fatigue, and unrefreshing sleep with normal labs; treat with exercise, sleep, and SNRIs/gabapentinoids.
- Type 2 diabetes first-line
- Metformin plus lifestyle; add GLP-1 RA or SGLT2 inhibitor (proven cardiorenal benefit) based on comorbidities.
- Diagnosing diabetes
- Fasting glucose ≥126, A1c ≥6.5%, 2-h OGTT ≥200, or random ≥200 with symptoms (confirm).
- DKA management
- IV fluids, insulin infusion, and potassium repletion; treat the precipitant; close the anion gap before stopping insulin.
- HHS vs DKA
- Hyperosmolar hyperglycemic state: very high glucose, high osmolality, minimal ketosis/acidosis — usually type 2.
- Hypothyroidism
- Fatigue, weight gain, cold intolerance; high TSH, low free T4; treat with levothyroxine.
- Hyperthyroidism (Graves)
- Low TSH, high free T4, TSI antibodies, diffuse goiter, orbitopathy; treat with methimazole, radioiodine, or surgery.
- Thyroid storm
- Life-threatening thyrotoxicosis; beta-blocker, thionamide, iodine (after thionamide), and steroids.
- Adrenal insufficiency
- Fatigue, hypotension, hyponatremia, hyperkalemia; low cortisol with high ACTH (primary); treat with hydrocortisone (stress-dose in illness).
- Cushing syndrome workup
- Confirm hypercortisolism (late-night salivary cortisol, 24-h urinary free cortisol, low-dose dexamethasone suppression), then localize.
- Pheochromocytoma
- Episodic headache, sweating, palpitations, hypertension; plasma/urine metanephrines; alpha-blockade before beta-blockade.
- Primary hyperaldosteronism
- Hypertension with hypokalemia; high aldosterone/renin ratio; the most common secondary HTN cause.
- Hypercalcemia causes
- Primary hyperparathyroidism (outpatient) and malignancy (inpatient) are the top two.
- Osteoporosis treatment
- Bisphosphonates are first-line; ensure calcium/vitamin D; T-score ≤ −2.5 or fragility fracture.
- Diabetic kidney protection
- ACEi/ARB and SGLT2 inhibitors slow progression of diabetic nephropathy with albuminuria.
- SIADH
- Euvolemic hyponatremia with concentrated urine and low serum osmolality; treat with fluid restriction (and the cause).
- Hyperlipidemia in diabetes
- Statin therapy for most adults with diabetes age 40–75 to reduce ASCVD risk.
- AKI categories
- Prerenal (low perfusion), intrinsic (ATN, GN), and postrenal (obstruction) — urine studies and FENa help differentiate.
- Prerenal vs ATN
- Prerenal: FENa <1%, high urine osmolality, bland sediment. ATN: FENa >2%, muddy-brown casts.
- CKD staging
- By GFR (G1–G5) and albuminuria (A1–A3); slow progression with BP control, ACEi/ARB, SGLT2i.
- Hyperkalemia ECG/treatment
- Peaked T waves → calcium gluconate (membrane stabilization), then insulin+glucose/albuterol to shift, then remove (diuresis, K-binders, dialysis).
- Anion gap
- Na⁺ − (Cl⁻ + HCO₃⁻); high gap acidosis mnemonic MUDPILES (methanol, uremia, DKA, etc.).
- Metabolic acidosis compensation
- Winter's formula: expected PCO₂ = 1.5 × HCO₃⁻ + 8 ± 2.
- Nephrotic vs nephritic
- Nephrotic: proteinuria >3.5 g/day, edema, hypoalbuminemia. Nephritic: hematuria, RBC casts, hypertension, mild proteinuria.
- Nephrolithiasis
- Calcium oxalate is the most common stone; non-contrast CT diagnoses; increase fluids, treat pain, may pass <5 mm spontaneously.
- Renal artery stenosis
- Secondary HTN; consider with a rise in creatinine after starting an ACEi/ARB or flash pulmonary edema.
- Hyponatremia approach
- Assess volume status and serum/urine osmolality; correct slowly (≤8 mEq/L per 24 h) to avoid osmotic demyelination.
- Contrast-associated AKI
- Risk in CKD/diabetes; hydrate; usually transient — true incidence is lower than once thought.
- Indications for dialysis (AEIOU)
- Acidosis, Electrolytes (refractory hyperkalemia), Intoxications, Overload (volume), Uremia (encephalopathy, pericarditis).
- Iron-deficiency anemia
- Microcytic, low ferritin, high TIBC; find the source (GI bleed in adults); replace iron.
- Anemia of chronic disease
- Normocytic/microcytic; normal-to-high ferritin, low TIBC; treat the underlying disease.
- B12 vs folate deficiency
- Both cause macrocytic anemia; only B12 deficiency causes neurologic deficits (check methylmalonic acid).
- Hemolytic anemia clues
- High LDH and indirect bilirubin, low haptoglobin, high reticulocytes; positive Coombs in autoimmune hemolysis.
- Sickle cell crisis
- Vaso-occlusive pain; hydrate, oxygenate, analgesia; hydroxyurea reduces frequency.
- ITP
- Isolated thrombocytopenia from antiplatelet antibodies; treat with steroids/IVIG if bleeding or very low counts.
- TTP pentad
- Thrombocytopenia, microangiopathic hemolysis, neuro changes, renal injury, fever; ADAMTS13 deficiency — urgent plasma exchange.
- HIT
- Heparin-induced thrombocytopenia: platelet drop ~5–10 days after heparin with thrombosis; stop all heparin, use a non-heparin anticoagulant.
- DIC
- Consumptive coagulopathy: low platelets/fibrinogen, high PT/PTT and D-dimer; treat the cause and support.
- Von Willebrand disease
- Most common inherited bleeding disorder; mucocutaneous bleeding, prolonged bleeding time; desmopressin for type 1.
- Polycythemia vera
- JAK2 mutation, high hematocrit, pruritus, thrombosis; phlebotomy and low-dose aspirin.
- Warfarin reversal
- Vitamin K for non-urgent; 4-factor PCC (plus vitamin K) for major bleeding.
- Tumor lysis syndrome
- After chemo of bulky tumors: high K⁺, phosphate, uric acid; low calcium — hydrate, allopurinol/rasburicase.
- Febrile neutropenia (onc)
- Oncologic emergency — empiric anti-pseudomonal antibiotics within an hour of fever.
- Spinal cord compression
- Back pain with neuro deficits in a cancer patient → emergent MRI and steroids, then radiation/surgery.
- SVC syndrome
- Facial/arm swelling, distended neck veins from tumor compression; often small-cell lung cancer or lymphoma.
- Hypercalcemia of malignancy
- PTHrP, bone metastases, or 1,25-vitamin D; treat with IV fluids and bisphosphonates.
- Lung cancer types
- Small-cell (central, paraneoplastic, rapid) vs non-small-cell (adeno most common); smoking is the major risk.
- Breast cancer screening
- Mammography for average-risk women, generally starting at 40–50 depending on guideline.
- Prostate cancer screening
- Shared decision-making about PSA, generally ages 55–69.
- Cervical cancer screening
- Pap ± HPV co-testing starting at 21; HPV-based screening at 25–30+ per guideline.
- Lung cancer screening
- Low-dose CT for adults 50–80 with a ≥20 pack-year history who currently smoke or quit within 15 years.
- Paraneoplastic SIADH
- Hyponatremia from ectopic ADH — classically small-cell lung cancer.
- Lymphoma B symptoms
- Fever, drenching night sweats, and weight loss >10% — adverse prognostic signs.
- Ischemic stroke tPA window
- IV thrombolysis within 4.5 hours of onset if no contraindication; thrombectomy for large-vessel occlusion in selected patients up to 24 h.
- Stroke vs TIA
- TIA has transient symptoms without infarction on imaging; both need urgent secondary-prevention workup.
- Status epilepticus
- Seizure >5 min or recurrent without recovery; benzodiazepine first, then a loading antiepileptic.
- Bacterial meningitis signs
- Fever, headache, neck stiffness, altered mental status; LP after imaging if indicated; do not delay antibiotics.
- Subarachnoid hemorrhage
- Thunderclap 'worst headache of life'; non-contrast CT, then LP (xanthochromia) if CT negative.
- Parkinson disease
- Resting tremor, bradykinesia, rigidity, postural instability; levodopa-carbidopa is most effective.
- Multiple sclerosis
- CNS demyelination disseminated in time and space; MRI lesions, oligoclonal bands; treat relapses with steroids.
- Guillain-Barré
- Ascending symmetric weakness with areflexia after infection; albuminocytologic dissociation; treat with IVIG or plasmapheresis; watch respiratory status.
- Myasthenia gravis
- Fatigable weakness (ptosis, diplopia); acetylcholine-receptor antibodies; treat with pyridostigmine and immunotherapy.
- Migraine vs tension headache
- Migraine: unilateral, throbbing, photophobia/phonophobia, nausea; treat acute with triptans, prevent if frequent.
- Delirium vs dementia
- Delirium is acute, fluctuating, with inattention (often reversible); dementia is chronic and progressive.
- Normal pressure hydrocephalus
- Triad: gait apraxia, urinary incontinence, dementia ('wet, wobbly, wacky'); may improve with shunting.
- Major depressive disorder
- ≥5 SIG-E-CAPS symptoms for ≥2 weeks including depressed mood or anhedonia; first-line is an SSRI plus psychotherapy.
- Serotonin syndrome
- Agitation, clonus, hyperreflexia, hyperthermia from serotonergic drugs; stop the agent, supportive care, cyproheptadine.
- Generalized anxiety disorder
- Excessive worry most days for ≥6 months; SSRIs/SNRIs and CBT first-line.
- Bipolar disorder caution
- Avoid antidepressant monotherapy (can precipitate mania); use mood stabilizers (lithium, valproate) or atypical antipsychotics.
- Lithium toxicity
- Tremor, ataxia, confusion; narrow therapeutic index worsened by dehydration, NSAIDs, ACEi, and thiazides.
- Alcohol withdrawal
- Tremor, tachycardia, seizures, delirium tremens; treat with benzodiazepines and thiamine (before glucose).
- Wernicke encephalopathy
- Thiamine deficiency: confusion, ataxia, ophthalmoplegia; give IV thiamine before glucose.
- Neuroleptic malignant syndrome
- Fever, rigidity, autonomic instability, elevated CK from antipsychotics; stop the drug, cool, dantrolene/bromocriptine.
- Opioid use disorder
- Treat with buprenorphine or methadone; naloxone reverses overdose.
- Capacity assessment
- A patient has decision-making capacity if they can communicate a choice, understand, appreciate, and reason about it.
- Stevens-Johnson / TEN
- Drug-induced mucocutaneous necrosis with sloughing (positive Nikolsky); stop the drug, supportive care (often burn unit).
- Melanoma ABCDE
- Asymmetry, Border irregularity, Color variation, Diameter >6 mm, Evolving — biopsy suspicious lesions.
- Erythema multiforme
- Target lesions, often from HSV or drugs.
- Psoriasis
- Well-demarcated plaques with silvery scale on extensor surfaces; topical steroids/vitamin D, phototherapy, or biologics.
- Cellulitis vs erysipelas
- Erysipelas is superficial with a sharply demarcated raised border (often Strep); cellulitis is deeper and less well-defined.
- Basal vs squamous cell carcinoma
- BCC: pearly papule with telangiectasias (rarely metastasizes). SCC: scaly/ulcerated, can metastasize.
- Drug reaction with eosinophilia (DRESS)
- Fever, rash, eosinophilia, and organ involvement weeks after a drug; stop the agent, supportive/steroids.
- Pemphigus vs pemphigoid
- Pemphigus vulgaris: flaccid bullae, positive Nikolsky, intraepidermal. Bullous pemphigoid: tense bullae, negative Nikolsky, subepidermal.
- Sensitivity vs specificity
- Sensitivity = true-positive rate (negative test rules OUT, SnNout); specificity = true-negative rate (positive test rules IN, SpPin).
- PPV depends on prevalence
- Positive predictive value rises with disease prevalence; likelihood ratios do not depend on prevalence.
- Number needed to treat
- NNT = 1 ÷ absolute risk reduction; fewer patients needed means greater benefit.
- Relative risk vs odds ratio
- RR compares incidence between groups (cohorts/RCTs); OR is used in case-control studies and approximates RR for rare outcomes.
- Confidence interval
- A 95% CI that crosses 1 (for RR/OR) or 0 (for differences) indicates a non-significant result.
- Preoperative cardiac risk
- Assess functional capacity (METs) and surgical risk; routine testing is not needed for low-risk surgery or good functional status.
- Adult immunizations
- Annual influenza; Tdap then Td/Tdap boosters; pneumococcal and RSV per age; zoster (RZV) at ≥50.
- Geriatric polypharmacy
- Review with the Beers criteria; deprescribe high-risk drugs (anticholinergics, benzodiazepines) in older adults.
- Falls in older adults
- Multifactorial; review medications, vision, gait/balance, and home hazards; strength/balance exercise reduces risk.
- Delirium prevention
- Reorient, mobilize, restore sleep, treat pain, hydrate, and remove tethers; avoid deliriogenic drugs.
- Palliative vs hospice
- Palliative care can accompany curative treatment at any stage; hospice is for a prognosis ~6 months when curative care is stopped.
- Advance directives
- A living will states wishes; a healthcare proxy/durable power of attorney names a surrogate decision-maker.
- USPSTF AAA screening
- One-time ultrasound for men 65–75 who have ever smoked.
- Osteoporosis screening
- DEXA for women ≥65 (and younger high-risk) to assess fracture risk.
- Smoking cessation
- Combine counseling with pharmacotherapy (varenicline, bupropion, or nicotine replacement) — most effective together.
- Diabetes prevention
- Intensive lifestyle change (weight loss, activity) and metformin reduce progression from prediabetes.
- Dressler syndrome
- Autoimmune pericarditis weeks after MI — fever, pleuritic chest pain, pericardial effusion; treat with NSAIDs/colchicine.
- Right ventricular MI
- Inferior MI with hypotension and clear lungs; preload-dependent — give fluids, AVOID nitrates.
- Hypertrophic cardiomyopathy murmur
- Systolic murmur that INCREASES with Valsalva/standing (less preload); risk of sudden death in young athletes.
- Mitral stenosis
- Opening snap and diastolic rumble; usually rheumatic; causes left atrial enlargement and atrial fibrillation.
- Endocarditis prophylaxis
- Antibiotics before dental procedures only for highest-risk hearts (prosthetic valve, prior endocarditis, certain congenital disease).
- DOAC vs warfarin in AF
- Direct oral anticoagulants are preferred over warfarin in non-valvular atrial fibrillation; warfarin is required for mechanical valves and rheumatic MS.
- Orthostatic hypotension
- Drop ≥20 systolic or ≥10 diastolic on standing; review volume status and medications.
- Cardiogenic shock
- Pump failure with hypotension and end-organ hypoperfusion; revascularize the cause; vasopressors/inotropes/mechanical support.
- Secondary prevention post-MI
- Aspirin, P2Y12 inhibitor, high-intensity statin, beta-blocker, and ACEi/ARB; cardiac rehab.
- Takotsubo cardiomyopathy
- Stress-induced apical ballooning mimicking ACS with normal coronaries; usually recovers.
- Sarcoidosis
- Non-caseating granulomas; bilateral hilar adenopathy, elevated ACE/calcium; many resolve, steroids for organ involvement.
- Asthma severity by control
- Step up if symptoms/rescue use are frequent or there are exacerbations; reassess and step down when stable.
- Alpha-1 antitrypsin deficiency
- Early panacinar (basilar) emphysema in a young non-smoker, often with liver disease.
- Obesity hypoventilation
- Daytime hypercapnia in obesity without another cause; treat with weight loss and positive-airway-pressure therapy.
- Exudative effusion causes
- Infection (parapneumonic/empyema), malignancy, PE, and inflammatory disease.
- Transudative effusion causes
- Heart failure, cirrhosis, and nephrotic syndrome (low oncotic / high hydrostatic pressure).
- Aspiration pneumonia
- Right lower/middle lobe predilection; risk with impaired swallow/consciousness; cover anaerobes/oral flora.
- Methacholine challenge
- Provocation test for asthma when spirometry is normal but asthma is suspected.
- Massive hemoptysis
- Airway protection, position bleeding side down, and urgent bronchoscopy/bronchial artery embolization.
- Zollinger-Ellison syndrome
- Gastrinoma causing refractory/multiple peptic ulcers and diarrhea; check fasting gastrin.
- Hepatocellular carcinoma surveillance
- Ultrasound (± AFP) every 6 months in cirrhosis and chronic hepatitis B.
- Wilson disease
- Copper overload in young patients: liver disease, neuropsychiatric signs, Kayser-Fleischer rings, low ceruloplasmin.
- Primary biliary cholangitis
- Middle-aged women with pruritus and fatigue; high alkaline phosphatase, anti-mitochondrial antibody; treat with ursodiol.
- Ascending cholangitis (Charcot triad)
- Fever, jaundice, and RUQ pain; biliary obstruction with infection — antibiotics and urgent biliary drainage (ERCP).
- Acute mesenteric ischemia
- Severe pain out of proportion to exam in an at-risk patient; surgical emergency.
- Microscopic colitis
- Chronic watery diarrhea with normal-appearing colon; diagnosed on biopsy; often drug-associated.
- NAFLD management
- Weight loss, control diabetes/lipids; the leading chronic liver disease in the developed world.
- Variceal bleed management
- Octreotide, antibiotics (prophylaxis), and endoscopic band ligation; non-selective beta-blocker for prevention.
- Syphilis stages
- Primary chancre, secondary rash (palms/soles), latent, and tertiary (gummas, neuro, cardiovascular); treat with penicillin.
- Lyme disease
- Erythema migrans bull's-eye rash; doxycycline for early disease; can cause carditis/Bell palsy/arthritis.
- Clostridial myonecrosis (gas gangrene)
- Crepitus, severe pain, systemic toxicity — emergent debridement plus penicillin/clindamycin.
- Osteomyelitis
- Bone infection; MRI is most sensitive; bone biopsy/culture guides prolonged antibiotics.
- Fever of unknown origin
- Fever ≥3 weeks without diagnosis after workup; causes: infection, malignancy, and connective-tissue disease.
- Catheter-related bloodstream infection
- Remove the line; blood cultures from line and periphery; Staph aureus and Candida need source control.
- Immune reconstitution syndrome
- Paradoxical worsening of an infection after starting ART as immunity recovers.
- Asymptomatic bacteriuria
- Do NOT treat (except in pregnancy or before urologic procedures) to avoid resistance.
- Influenza antiviral
- Oseltamivir is most effective within 48 hours of symptom onset, especially in high-risk patients.
- Antiphospholipid syndrome
- Recurrent thrombosis and/or pregnancy loss with antiphospholipid antibodies; anticoagulate.
- Polyarteritis nodosa
- Medium-vessel vasculitis sparing the lungs; associated with hepatitis B; renal/GI/skin involvement.
- Reactive arthritis
- Post-infectious triad: arthritis, conjunctivitis, urethritis ('can't see, pee, or climb a tree'); HLA-B27.
- Drug-induced lupus
- Anti-histone antibodies; from hydralazine, procainamide, isoniazid; resolves after stopping the drug.
- Dermatomyositis
- Proximal weakness with Gottron papules and heliotrope rash; elevated CK; screen for underlying malignancy.
- Adult-onset Still disease
- Quotidian fevers, salmon-colored rash, arthritis, very high ferritin.
- Septic vs gout joint
- Always tap an acute hot joint; Gram stain/culture and crystal analysis — septic arthritis can coexist with crystals.
- Methotrexate monitoring
- Check CBC, liver enzymes, and creatinine; supplement folic acid; avoid in pregnancy.
- Subclinical hypothyroidism
- High TSH with normal free T4; treat if TSH >10, symptomatic, or pregnant/planning pregnancy.
- Thyroid nodule workup
- Ultrasound and TSH; fine-needle aspiration for suspicious features or size criteria.
- Hypoglycemia (Whipple triad)
- Low glucose, consistent symptoms, and relief with glucose; evaluate for insulinoma vs medication.
- Diabetes monitoring target
- A1c goal commonly <7% for most adults, individualized for frailty/hypoglycemia risk.
- Acromegaly
- Excess growth hormone (pituitary adenoma); check IGF-1, confirm with oral glucose tolerance test.
- Prolactinoma
- Most common pituitary tumor; galactorrhea, amenorrhea; first-line is a dopamine agonist (cabergoline).
- Diabetic foot care
- Annual monofilament exam; treat ulcers with offloading, debridement, and infection control.
- Hyperparathyroidism
- High calcium with high/inappropriately normal PTH; parathyroidectomy for symptoms or end-organ effects.
- IgA nephropathy
- Most common glomerulonephritis; hematuria days after an upper respiratory infection.
- Diabetic nephropathy
- Leading cause of ESRD; albuminuria; protect with ACEi/ARB and SGLT2 inhibitors.
- Rhabdomyolysis
- Muscle breakdown with very high CK, myoglobinuria, and AKI; aggressive IV fluids; watch potassium.
- Renal tubular acidosis
- Non-anion-gap metabolic acidosis; type 1 (distal), type 2 (proximal), type 4 (hyperkalemic, hypoaldosterone).
- Hypernatremia
- Free-water deficit; correct slowly (<10–12 mEq/L per day) to avoid cerebral edema.
- Hypokalemia ECG
- U waves, flat T waves, and risk of arrhythmia; replace potassium and correct magnesium.
- Contrast nephropathy prevention
- Use the lowest contrast volume and hydrate in at-risk patients.
- Multiple myeloma (CRAB)
- hyperCalcemia, Renal failure, Anemia, Bone lesions; M-spike, plasma cells in marrow.
- Chronic lymphocytic leukemia
- Most common adult leukemia; smudge cells; often indolent and found incidentally.
- Acute promyelocytic leukemia
- AML M3 with t(15;17); DIC risk; treat with all-trans retinoic acid (ATRA).
- Hodgkin lymphoma
- Reed-Sternberg cells; contiguous nodal spread; highly curable.
- G6PD deficiency
- Episodic hemolysis after oxidant stress (drugs, fava beans, infection); bite cells and Heinz bodies.
- Thalassemia vs iron deficiency
- Both microcytic; thalassemia has a normal/high RBC count and normal ferritin; check hemoglobin electrophoresis.
- Hypercoagulable workup
- Consider after unprovoked or recurrent VTE — factor V Leiden, prothrombin mutation, protein C/S, antithrombin, antiphospholipid.
- Colorectal cancer follow-up
- Surveillance colonoscopy and CEA monitoring after curative resection.
- Testicular cancer markers
- AFP, beta-hCG, and LDH; highly curable even when metastatic.
- Prostate cancer staging
- PSA, Gleason score, and imaging; options range from active surveillance to surgery/radiation/ADT.
- Pancreatic cancer
- Painless jaundice, weight loss, CA 19-9; poor prognosis; often unresectable at diagnosis.
- Immunotherapy toxicity
- Checkpoint inhibitors cause immune-related colitis, pneumonitis, hepatitis, and endocrinopathies — treat with steroids.
- Cancer of unknown primary
- Metastatic disease without an identified source; tailor workup by histology/immunostains.
- Stroke secondary prevention
- Antiplatelet (or anticoagulation for AF), high-intensity statin, BP control, and carotid evaluation.
- Bell palsy
- Acute peripheral (whole-face) CN VII palsy; treat with steroids ± antivirals.
- Trigeminal neuralgia
- Brief, severe lancinating facial pain; carbamazepine is first-line.
- Essential tremor
- Action/postural tremor improving with alcohol; treat with propranolol or primidone.
- Carpal tunnel syndrome
- Median nerve compression; nocturnal hand numbness; splinting, then steroid injection or surgery.
- Cluster headache
- Severe unilateral periorbital pain with autonomic features; high-flow oxygen and triptans abort.
- Diabetic peripheral neuropathy
- Distal symmetric 'stocking-glove' sensory loss; treat pain with SNRIs, gabapentinoids, or TCAs.
- Suicide risk assessment
- Assess ideation, plan, intent, access to means, and prior attempts; ensure safety.
- PTSD
- Re-experiencing, avoidance, hyperarousal, and negative cognition after trauma; SSRIs and trauma-focused therapy.
- Panic disorder
- Recurrent unexpected panic attacks with anticipatory anxiety; CBT and SSRIs.
- Anorexia nervosa risks
- Restriction with low body weight; watch refeeding syndrome (low phosphate) and bradycardia.
- Benzodiazepine risks
- Tolerance, dependence, falls, and cognitive impairment — avoid long-term use, especially in older adults.
- Antidepressant onset
- SSRIs take 4–6 weeks for full effect; continue 6–12 months after remission of a first episode.
- Pityriasis rosea
- Herald patch followed by a 'Christmas-tree' truncal eruption; self-limited.
- Actinic keratosis
- Rough scaly sun-damaged lesions; premalignant for squamous cell carcinoma.
- Contact dermatitis
- Type IV hypersensitivity in the distribution of the allergen; topical steroids and avoidance.
- Acanthosis nigricans
- Velvety hyperpigmented skin in folds; associated with insulin resistance (and rarely GI malignancy).
- Dermatitis herpetiformis
- Intensely pruritic vesicles on extensors; associated with celiac disease.
- Type I vs type II error
- Type I (alpha) = false positive (reject a true null); Type II (beta) = false negative; power = 1 − beta.
- p-value meaning
- The probability of results as extreme as observed if the null hypothesis were true; <0.05 is conventionally significant.
- Lead-time vs length-time bias
- Lead-time: earlier detection only seems to prolong survival; length-time: screening preferentially finds slow-growing disease.
- Intention-to-treat analysis
- Analyze participants in their assigned group regardless of adherence — preserves randomization and reduces bias.
- Cohort vs case-control
- Cohort follows exposure forward to outcome (gives incidence/RR); case-control starts from outcome backward (gives odds ratio).
- Hospice eligibility
- A prognosis of about 6 months or less if the disease runs its usual course, with a focus on comfort.
- Pressure injury prevention
- Reposition, offload, manage moisture, and optimize nutrition in immobile patients.
- Urinary incontinence types
- Stress (leak with cough), urge (overactive bladder), overflow (retention), and functional.
- Perioperative anticoagulation
- Balance bleeding vs thrombosis risk; bridge only high-risk patients; hold DOACs based on renal function and bleeding risk.
- Vaccination in immunocompromised
- Avoid live vaccines; give inactivated vaccines and pneumococcal series.
- Hypertension diagnosis
- Confirm with out-of-office (ambulatory/home) readings; stage 1 is ≥130/80 by current US guidelines.
- Obesity pharmacotherapy
- GLP-1 receptor agonists (semaglutide) and other agents added to lifestyle for BMI ≥30 (or ≥27 with comorbidity).